Compare LEGH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LEGH | YDES |
|---|---|---|
| Founded | 2005 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Homebuilding | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 620.7M | 543.0M |
| IPO Year | 2018 | 2024 |
| Metric | LEGH | YDES |
|---|---|---|
| Price | $28.30 | $3.54 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 112.7K | 37.8K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | ★ $164,567,000.00 | N/A |
| Revenue This Year | $11.90 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $19.70 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.29 | $1.70 |
| 52 Week High | $31.34 | $25.00 |
| Indicator | LEGH | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 55.45 | 46.24 |
| Support Level | $28.00 | $2.88 |
| Resistance Level | $31.34 | $5.24 |
| Average True Range (ATR) | 0.97 | 0.62 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 17.00 | 27.20 |
Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.